Futuximab, CAS 1310460-85-5

Product Description: Futuximab is a chimeric monoclonal antibody targeting non-overlapping epitopes on EGFR. Futuximab has antineoplastic activity[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Stephen T Keir, et al. Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models. J Neurooncol. 2018 Jul;138(3):489-498.

CAS Number: 1310460-85-5

Molecular Weight: N/A

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: EGFR

• Artikelnummer: MEXHY-P99628-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99628-5
• Verpackungseinheit: 5mg
• Mengeneinheit: STK
• Konjugat: Unconjugated